New strategy for treating visceral pain: Enhancing opioid antinociception by Sigma-1 receptor inhibition
- 27 May 2026
- journal article
- Published by Elsevier in The Journal of Pain
- Vol. 46, 106329
Abstract
No abstract availableKeywords
Funding Information
- Ministerio de Ciencia, Innovación y Universidades (PID2023-148753OB-100)
- Ministerio de Economía y Competitividad (FPU21/02736)
This publication has 60 references indexed in Scilit:
- Involvement of TRPV1 and MOR-NMDAR complex on the antiallodynic effect of LMH-2, a sigma-1 receptor antagonist, in mouse model of diabetic neuropathy - a behavioral approachPharmacological Reports, 2025
- E‐52862—A selective sigma‐1 receptor antagonist, in peripheral neuropathic pain: Two randomized, double‐blind, phase 2 studies in patients with chronic postsurgical pain and painful diabetic neuropathyEuropean journal of pain, 2024
- Sigma-1 Receptors Control Neuropathic Pain and Peripheral Neuroinflammation After Nerve Injury in Female Mice: A Transcriptomic StudyJournal of Neuroimmune Pharmacology, 2024
- Pain management with opioids in adultsJournal of Neuroscience Research, 2020
- Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical TrialNeurotherapeutics, 2017
- Pharmacological Modulation of the Sigma 1 Receptor and the Treatment of Pain2017
- Sigma-1 Receptor Antagonists: A New Class of Neuromodulatory Analgesics2017
- Sigma-1 Receptor and Pain2017
- Characterization of two novel σ receptor ligands: antidystonic effects in rats suggest σ receptor antagonismEuropean Journal of Pharmacology, 1995
- Sigma antagonists potentiate opioid analgesia in ratsNeuroscience Letters, 1995